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The treatment modalities considered here are not nec-
essarily confined to CLI patients but are sometimes
also used in claudicants.
D 4.16.1
Transfusion of Ultraviolet Irradiated Autologous Blood
This technique is widely used in patients with PAD in
all stages, mostly in eastern countries of Europe and
Russia. Photohaemotherapy consists of ultraviolet
radiation of autologous blood. Although a few uncon-
trolled studies showed an improvement of rheological
properties of the blood, there is no controlled prospec-
tive study in patients with IC or CLI showing a clear
clinical benefit for the treated patients.'
D 4.16.2
Hyperbaric Oxygen
The initial reports on the use of hyperbaric oxygen in
patients with early gangrene of the legs were encour-
aging, because relief of pain was obtained and ampu-
tations could be postponed, even for several yearsP
In an uncontrolled study, 18% of diabetic patients with
ulcers refractory to conventional treatment had com-
plete healing, but all made at least a fair response.
Seventy-five percent of atherosclerotic ulcers in nondi-
abetic patients improved sufficiently to allow patients
to return horne and resume daily activities.' The
longest and largest experience was reported by
Fredenucci,? who collected data on more than 2,000
patients treated in over 70,000 sessions between 1966
and 1983. Relief of rest pain and healing of limiting
ulcers was observed in one third of patients after 4 to
6 weeks of treatment. The therapy is cumbersome, and
it is also unclear to what extent the clinical results can
be attributed to concomitant therapy, including
heparin infusion. All of the reported studies were
uncontrolled. This treatment cannot be recommended
until prospective controlled trials have shown it to be
beneficial.
Local treatment with hyperbaric oxygel/
Although local hyperbaric oxygen with topical hyper-
baric oxygen chamber technique has undergone real
waves of enthusiasm, its use for treatment of ulcers
due to CLI or for stump healing problerns.s? remains
to be more clearly demonstrated by randomised clini-
cal trials.
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D 4.16.3
Ambulation, Intermittent Venous Compression,
Negative Pressure Application
Limited walking and intermittent compression of the
foot, calf, or both have been shown to increase blood
flow and foot TCP02 in limbs with PAD.8,9,IO,IU2,13
Limited walking in patients with chronic CLI was sug-
gested in the Second European Consensus Document
on Chronic Critical Limb Ischaemia,'! and Foley
reported on the treatment of gangrene by walking.n
There is some evidence that increased blood flow in
response to walking or intermittent venous compres-
sion may be contributed to further in some cases by
the inhibition of vena-arteriolar reflex vasoconstric-
tion or by endothelium-mediated mechanisms.u-P
Similarly, application of external negative pressure to
the leg increased skin blood flow in the foot of patients
with PAD and increased walking distance in patients
with IC.16,17 These and similar approaches may be of
benefit in the management of patients with PAD, espe-
cially when interventional treatment is not indicated,
but their value needs to be ass essed by properly
designed clinical trials.
Critical Issue 44: Limited walking. intermittent
p-neumatic comp-ression. negative wessure ap-p-lica-
tion in p-erip-heral arterial disease
There is a need for properly designed studies to
determine the benefit of limited walking, intermit-
tent pneumatic compression, and negative pressure
application in treatment of peripheral arterial
disease.
D 4.16.4
Epidural Spinal Cord Stimulation
In some vascular centres in Europe, spinal cord stimu-
lation (SCS) has been used since the late 1960s in
patients with intractable pain caused by CLI, as an
alternative to amputation. The technique involves
implantation of an electrode at the level of L3-L4 and
a pulse generator subcutaneously. This method is used
not only to relieve leg pain but also as a means of
maintaining circulation in the leg. In one uncontrolled
study, 94% of the 38 patients treated with SCS experi-
enced pain relief, and in half of the patients, healing of
ischemic ulcers occurred.v In another uncontrolled
study, immediate relief of rest pain was seen in 18 of
20 CLI patients. Of these, 12 patients had continued
pain relief and healing of ischaemic ulcers, with
improved microcirculatory flow suggested by capil-
laroscopy.'? Nevertheless, the real mechanism of
action of SCS is unknown, and the appropriate place
for this form of therapy remains to be determined.
Prospective studies are needed to show the value of
SCS20,21 (see also D 4.2.1, Control of Pain, p SI64).
Two controlled studies ha ve been published on the
efficacy of SCS in patients with inoperable severe
CLI.u.23 In the first study, patients with inoperable
severe CLI were randomised to either SCS or analgesic
treatment only with 18 months' follow-up.v Long-
term pain relief was observed only in the SCS group.
Limb salvage rates did not differ at the end of the fol-
low-up period, although tissue loss was significantly
less in the SCS group, and a subgroup analysis
showed that patients without arterial hypertension
had a lower amputation rate if treated with SCS.u In
the second study, patients with inoperable severe CLI
were randomised to -either SCS plus best medical
treatment or best medical treatment only.23 Median fol-
low-up was 605 days (interquartile range, 244-1,771) .
There was no difference in mortality between the two
groups, and the major amputation rate was insignifi-
cantly lower in the SCS plus medical treatment group
(42% vs 48%, P = 0.47).
Recommendation 100: fu2inal cord stimulation in
critical limb ischaemia
On current evidence, spinal cord stimulation can-
not be recommended in the treatment of critical
limb ischaemia.
D 4.16.5
Chelation Therapy
Chelation therapy has been promoted as a means to
treat atherosclerosis and relieve symptoms of cardio-
vascular disease. However, there is no scientific basis
to support these claims. Four randomised, double-
blind, multicentre trials of ethylenediaminetetra-acetic
acid (EDTA) in patients with PAD have been recently
reviewed." The drug was not shown to be effective in
treating the symptoms of claudication in any of these
studies, nor in improving the ABPI. Furthermore, fre-
quent infusions of EDTA may produce severe hypocal-
caemia and therefore actually may be dangerous.
Recommendation 101: Chelation therapy in p-eriph-
eral arterial disease
There is no scientific basis for the use of chelation
therapy in the treatment of peripheral arterial
disease.
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Sympathectomy in the Management of Critical Limb
Ischaemia
Among patients with atherosclerotic arterial occlusion
or thromboangiitis obliterans, lumbar sympathectomy
ha s been limited to patients with inoperable disease
complicated by rest pain and tissue loss.
Sympathectomyto treat iscltaentic rest pain
Symptom relief has been reported in 47% to 71% of
unselected patients, with limb salvage in 60% to 94%.25
The best results were obtained by Persson's among 37
patients who had an ABPI greater than 0.3, no evi-
dence of neuropathy, and very limited tissue necrosis.
In this series, 78% of patients had long-term relief of
ischaernic pain, and 11% required amputation. The
worst results were noted by Fulton and Blakely" in 17
unselected patients undergoing sympathectomy, with
only 6% obtaining relief, whereas 70% required early
amputation. Disappointing results therefore can be
expected when limb-threatening ischaemia is unselec-
tively treated by sympathectomy.
Sympathectomy to treat tissue loss
Less impressive results than for rest pain are general-
ly noted, with 35% to 62% of patients showing com-
plete initial healing of the ischaemic lesions. In addi-
tion, amputation rates were higher than in the rest
pain group, with a range of 27 to 38%.25 Persson et aJ26
again reported the best results in 22 patients who had
adequate inflow, no neuropathy, and no evidence of
infection; 77% had ulcer healing, and only 22%
required amputation.
Sympathectomyas alladjunctfor lower-extremity
reoascularisation
Because lumbar sympathectomy increases lower-
extremity blood flow at least temporarily, it has been
suggested as an adjunct during aortoiliac reconstruc-
tion in an attempt to improve outflow and graft paten-
cy. However, subsequent randomised trials failed to
show any difference in clinical outcome or graft paten-
cy when sympathectomy was added during
aortofemoral bypass.2S,29 Thus, this technique is no
longer practiced. There have not been trials of the
effect of sympathectomy on infrainguinal bypass
patency or efficacy, but the requirement for a separate
incision discourages this approach. A benefit of tem-
porary chemical sympathectomy provided by epidur-
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al anaesthesia was suggested in one randomised trial
that showed improved early infrainguinal graft paten-
cy.3D However, two subsequent trials failed to show
this effect.3 1,32 Currently, there is no established role for
adjuvant surgical sympathectomy to improve bypass
graft patency or efficacy.
Current indications for lumbar sympathectomy
Primary indications for lumbar sympathectomy are
limited to selected patients with inoperable distal arte-
rial occlusive disease secondary to arteriosclerosis or
thromboangiitis obliterans. Current determination of
inoperability differs with expertise and availability of
saphenous vein. In rare cases in which such revascu-
larisation procedures are not feasible because of inade-
quate run-off, lumbar sympathectomy may be consid-
ered in the patients with (1) ABPI greater than 0.3; (2)
superficial tissue necrosis limited to digits; (3) absent
neuropathy (diabetes); (4) symptom relief after lumbar
sympathetic blockade, and (5) acceptable surgical risk
for a retroperitoneal approach. The most common
complications of lumbar sympathectomy are tempo-
rary neuralgia and inadequate clinical improvement.w
Recommendation 102: Lumbar sympathectomy in
critical1imb ischaemia
There is currently insufficient scientific evidence
for the selection of patients likely to benefit from
lumbar sympathectomy for the treatment of critical
limb ischaemia.
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D 4.17
Amputation
Because patients with severe lower extremity
ischaemia have a high incidence of coexisting myocar-
dial, cerebrovascular and renal disease, their operative
risk is significantly elevated. Therefore the indications
for amputation, selection of the appropriate level and
surgical management of these patients must clearly be
established prior to the procedure to avoid the need
for revision or re-amputation (see A 2.9.2, Risk Factors
for Major Amputation, p 522).
D 4.17.1
Indications for Amputation
Primarf amputation
Primary amputation is defined as amputation of the
ischaemic lower extremity without an antecedent
attempt at revascularisation. Amputation is considered
as primary therapy for lower limb ischaemia only in
selected cases. Unreconstructable arterial disease is
generally due to the progressive nature of the underly-
ing atherosclerotic occlusive disease. Newer imaging
techniques, such as magnetic resonance angiography,
duplex ultrasonography, and more recently, high-reso-
lution digital angiography, have improved the ability
of physicians to pre-operatively detect patent distal
vessels that might serve as suitable recipient sites for
the construction of a bypass.' The complete absence of
detectable distal vessels, using modem imaging tech-
niques, especially in the setting of advanced distal
ischaemia associated with a low ABPI «0.30), suggests
that vascular reconstruction is not possible and that
major amputation is inevitable.s> These patients are
best served by primary amputation.'
Ulceration and necrosis of the weight-bearing sur-
face of the foot are frequent causes of amputation. In a
recent study of more than 200 patients requiring
amputation loss of the foot pads at the level of the dig-
its, metatarsophalangeal joints and the heel was the
indication for amputation in more than 75% of cases.f
Loss of the heel renders revascularisation useless for
preservation of ambulation,» The use of myocutaneous
free flaps for the replacement of necrotic muscle and
skin has been reported as a technique for extending
limb salvage in selected patients? This aggressive vas-
cular reconstructive effort, however, may be associat-
ed with multiple procedures, a recuperative period of
more than 6 months and yields flap survival in the
range of 50% to 62% and a functional foot in 50% to
86%, respectively.8.9.1O.1I As vascular reconstruction in
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